Manufacturing

Agnes Shanley is senior editor of Pharmaceutical Technology.

Articles

An example of a new cold chain temperature-controlled shipping technology is Cocoon, which was commercialized in November 2016 and designed for use with pallet-sized shippers.

Last-mile temperature control

Brian Keesee is Executive Director for North America Operations, PCI Clinical Services.

Cold-chain requirements and the tight logistical windows needed for cell and gene therapies demand a focus on early communication and risk mitigation.

Careful, Early Cold-Chain Planning is Crucial for New Biologics

Andrea Zobel, senior director of product management, clinical trial supply, and logistics at PAREXEL International, examines key issues and questions that sponsors and contract partners must address.

Preparing an Approach to Cold Chain for Cell- and Tissue-Based Therapies

Staffan Widengren is director of corporate projects at Recipharm and program manager for the Recipharm global serialization project. He has been working as quality director and general manager within the Recipharm Group since 2002.

Many pharmaceutical manufacturers were late in involving contract partners in serialization efforts. Are you ready, and are you working with the right partner?

Serialization: The Final Countdown

Haris Kamal is senior vice-president of Verify Brand.

As the date for implementation of the Drug Supply Chain Security Act approaches, bio/pharma companies and contractors should focus on key areas.

Serialization Preparation Prompts Data and Business Questions

Currently, pharmaceutical manufacturers are said to waste $25 billion on supply chain inefficiencies. Technology offers a way to achieve transparency and results.

The Digital Supply Chain: Seizing Pharma’s Untapped Opportunity

Charlotte Hicks is an independent supply chain management and risk consultant based in Raleigh, NC.

Supply chain risk monitoring is crucial for any company doing business today, and it doesn’t have to be expensive.

Zero Budget Supply Chain Risk-Monitoring and Mitigation

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

A new report says that failure to account for rebates, discounts, and price concessions leads to an “overstatement of payments realized by manufacturers” in most annual industry drug spend reports.

Pharma Manufacturers Say Supply Chain Stakeholders Now Getting a Bigger Cut

B&W Tek’s director of Market and Customer Development, Katherine A. Bakeev, PhD, discusses analysis of pharmaceutical raw materials and the benefits of using handheld Raman spectrometers.

Analysis of Raw Materials

TraceLink’s first Drug Supply, Safety and Traceability Report suggests that 19% of pharma companies, 11% of distributors, and 9% of dispensers still haven’t begun to address lot-level serialization requirements. Only 20% say their CMOs will be ready for the November 2017 deadline.